Friday, February 12, 2021

Indian state asks to halt the country's homegrown vaccine till trials are complete

A state in India has asked the federal government to halt the supply of Covaxin, which is India's indigenous COVID 19 vaccine.

Covaxin is still undergoing its third phase of clinical trials, but the Indian government authorised it for use in the country's COVID 19 inoculation drive.

Sreoshi Muukherjee reports...

IN: "The health minister..."
OUT: SOC
DUR: 0:46 seconds